Unjha Pharmacy Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.11 M
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth %
- Profit Growth 4.90%
- Ebitda 39.12%
- Net Worth -1.66%
- Total Assets -0.19%
About Unjha Pharmacy
Unjha Pharmacy Private Limited (UPPL) is a Private Limited Indian Non-Government Company incorporated in India on 15 April 1991 and has a history of 33 years and ten months. Its registered office is in Ahmedabad, Gujarat, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.11 M, as per Ministry of Corporate Affairs (MCA) records.
Jashvant Shah, Hitenkumar Shah, and Siddharth Shah serve as directors at the Company.
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24231GJ1991PTC015436
- Company No.
015436
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Apr 1991
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Unjha Pharmacy?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hitenkumar Shah  | Managing Director | 15-Apr-1991 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Jashvant Shah | Director | 15-Apr-1991 | Current |
| Siddharth Shah | Director | 15-Apr-1991 | Current |
Financial Performance of Unjha Pharmacy.
Unjha Pharmacy Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 4.9% increase in profit. The company's net worth dipped by a decrease of 1.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Unjha Pharmacy?
In 2021, Unjha Pharmacy had a promoter holding of 67.59% and a public holding of 32.41%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ayusiddh Health Care Private LimitedSiddharth Shah is a mutual person
Unjha Pharmaceuticals Private LimitedJashvant Shah is a mutual person
- Aura Nutraceuticals Limited
Jashvant Shah is a mutual person
- Unjha Healthcare Private Limited
Hitenkumar Shah is a mutual person
- Ayuda Herbal Private Limited
Hitenkumar Shah is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Unjha Pharmacy?
Unlock and access historical data on people associated with Unjha Pharmacy, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Unjha Pharmacy, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Unjha Pharmacy's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.